Caleres (NYSE:CAL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.2%

Caleres (NYSE: CAL) reported Q2 CY2026 sales of $695.5M, up 5.6% YoY but below estimates. Non-GAAP EPS of $0.47 beat forecasts by 27%. Revenue growth has averaged 2.4% annually over five years, with flat performance in the last two years. Operating margin improved to 11.2%, up 8.6 percentage points YoY. EPS declined 12.6% annually over five years despite revenue growth. Stock rose 5.2% post-results.

Original reporting
Published Sep 9, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Caleres (NYSE:CAL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.2% — source image
Decision brief

The 30-second read

$CALBullishHigh
01

Why it matters

The earnings beat sparked a 5.2% stock surge, indicating immediate trader interest; however, guidance shortfalls may temper longer‑term sentiment.

02

Market read

First‑report earnings surprise for a mid‑cap consumer discretionary stock, generating short‑term trading opportunity.

03

What to watch

Rising interest expenses and flat revenue growth over two years may pressure margins going forward.

Relevance 8/10Novelty 8/10Timing: post-earnings today

Background

Caleres reported Q2 CY2026 results with revenue up 5.6% YoY but missing consensus, while EPS beat and operating margin improved.

Company-level read

Ticker impact

$CALBullishHigh confidence
Context

Q2 2026 earnings beat EPS expectations and the stock jumped 5.2% after release.

Expected impact

Expect continued upside pressure in the near term as investors digest the beat.

Evidence & confidence

The beat was fresh, the stock already rose 5.2% on the news, and guidance remains modest, suggesting momentum may persist.

Market effects

Footwear and broader consumer discretionary may see modest lift as a mid‑cap beats expectations.

U.S. consumer discretionary stocks could see short‑term buying pressure.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

Despite the beat, revenue missed estimates and long‑term growth remains weak, suggesting the rally could be short‑lived.

Key entities

  • Caleres

    Footwear retailer (NYSE:CAL) reporting Q2 earnings.

Related articles

$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

$CALHighAI 8/10

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.

$CALMedAI 8/10

Caleres Q2 Earnings Call Highlights

Caleres (CAL) reported Q2 sales growth across its brands, with Sam Edelman up mid-teens, Allen Edmonds low teens, and Naturalizer high single digits. Vionic saw sales decline but earnings increased. Stuart Weitzman integration is progressing. Famous Footwear faced athletic category pressure, with sales down 6.3%. Caleres updated guidance, raising the lower end of its full-year adjusted EPS outlook to $1.50-$1.65.

$CALHighAI 8/10

Caleres Reports Second Quarter 2026 Results

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6% YoY. Brand Portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. GAAP EPS was $1.71, exceeding guidance. The company expects low-single-digit sales growth in Q3 and FY 2026, with improved gross margins.